Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 261

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Integrative Genome Comparison of Primary and Metastatic Melanomas

Open access
Kabbarah, Omar, Nogueira, Cristina, Feng, Bin, Nazarian, Rosalynn M., Bosenberg, Marcus, Wu, Min, Scott, Kenneth L., Kwong, Lawrence N., Xiao, Yonghong, Cordon-Cardo, Carlos, Granter, Scott R., Ramaswamy, Sridhar, Golub, Todd, Duncan, Lyn M., Wagner, Stephan N., Brennan, Cameron, Chin, Lynda·2010·PLoS ONE

Abstract

A cardinal feature of malignant melanoma is its metastatic propensity. An incomplete view of the genetic events driving metastatic progression has been a major barrier to rational development of effective therapeutics and prognostic diagnostics for melanoma patients. In this study, we conducted global genomic characterization of primary and metastatic melanomas to examine the genomic landscape associated with metastatic progression. In addition to uncovering three genomic subclasses of metastastic melanomas, we delineated 39 focal and recurrent regions of amplification and deletions, many of which encompassed resident genes that have not been implicated in cancer or metastasis. To identify progression-associated metastasis gene candidates, we applied a statistical approach, Integrative Genome Comparison (IGC), to define 32 genomic regions of interest that were significantly altered in metastatic relative to primary melanomas, encompassing 30 resident genes with statistically significant expression deregulation. Functional assays on a subset of these candidates, including MET, ASPM, AKAP9, IMP3, PRKCA, RPA3, and SCAP2, validated their pro-invasion activities in human melanoma cells. Validity of the IGC approach was further reinforced by tissue microarray analysis of Survivin showing significant increased protein expression in thick versus thin primary cutaneous melanomas, and a progression correlation with lymph node metastases. Together, these functional validation results and correlative analysis of human tissues support the thesis that integrated genomic and pathological analyses of staged melanomas provide a productive entry point for discovery of melanoma metastases genes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0010770

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 51 references

Cited by

See all 261

Metadata

Authors
Kabbarah, O., Nogueira, C., Feng, B., Nazarian, R. M., Bosenberg, M., Wu, M., Scott, K. L., Kwong, L. N., Xiao, Y., Cordon-Cardo, C., Granter, S. R., Ramaswamy, S., Golub, T., Duncan, L. M., Wagner, S. N., Brennan, C., & Chin, L.
Venue
PLoS ONE
Published
2010-05-24
Volume
5
Issue
5
Pages
e10770
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2125635172
Cited by
261
References
51
FWCI
4.27
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Integrative Genome Comparison of Primary and Metastatic Melanomas. https://app.cochat.ai/papers/10.1371/journal.pone.0010770
The paper
Kabbarah, O., Nogueira, C., Feng, B., Nazarian, R. M., Bosenberg, M., Wu, M., Scott, K. L., Kwong, L. N., Xiao, Y., Cordon-Cardo, C., Granter, S. R., Ramaswamy, S., Golub, T., Duncan, L. M., Wagner, S. N., Brennan, C., & Chin, L. (2010). Integrative Genome Comparison of Primary and Metastatic Melanomas. PLoS ONE. https://doi.org/10.1371/journal.pone.0010770

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.